Schinazi Raymond F 4
4 · Cocrystal Pharma, Inc. · Filed Oct 29, 2019
Insider Transaction Report
Form 4
Schinazi Raymond F
Director10% Owner
Transactions
- Purchase
Common Stock
2019-10-24$1.15/sh+5,094$5,858→ 9,249,957 total - Purchase
Common Stock
2019-10-23$1.04/sh+3,935$4,087→ 9,244,863 total - Purchase
Common Stock
2019-10-25$1.15/sh+7,906$9,092→ 9,257,863 total
Holdings
- 995,593(indirect: By LP)
Common Stock
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $0.965 to $1.08, inclusive. The reporting person undertakes to provide to Cocrystal Pharma, Inc., any security holder of Cocrystal Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in the footnote of this Form 4.